(478) TRV130, a novel biased opioid ligand, elicits increased analgesia with reduced adverse effects compared to morphine in healthy volunteers
Autor: | Soergel, D., Subach, R., James, I., Violin, J., Skobieranda, F., Sadler, B., Burnham, N., Theisen, T., Lark, M., Webster, L. |
---|---|
Zdroj: | In Journal of Pain April 2014 15(4) Supplement:S95-S95 |
Databáze: | ScienceDirect |
Externí odkaz: |